Tim Kobelt, Jonas Klose, Rumjhum Mukherjee, Martin Lippmann, Szymon P Szafranski, Meike Stiesch, Stefan Zimmermann
{"title":"Identification of anaerobic bacterial strains by pyrolysis-gas chromatography-ion mobility spectrometry.","authors":"Tim Kobelt, Jonas Klose, Rumjhum Mukherjee, Martin Lippmann, Szymon P Szafranski, Meike Stiesch, Stefan Zimmermann","doi":"10.3389/fbioe.2025.1582565","DOIUrl":null,"url":null,"abstract":"<p><p>The rapid identification of bacterial pathogens is critical for the early diagnosis of severe clinical conditions, such as sepsis or implant-associated infections, and for the initiation of timely, targeted therapies. This need is particularly acute within the complex oral microbiome, where diverse opportunistic pathogens contribute to a range of local and systemic diseases. While techniques such as phenotypic systems and MALDI-TOF-MS offer faster results, they remain limited by costs, and operational constraints. To address these challenges and cater to the need for rapid identification of bacteria, we present a system for identification and classification of anaerobic bacteria as a first example. This system combines a pyrolyzer, a gas chromatograph and a highly sensitive ion mobility spectrometer. The ion mobility spectrometer has been optimized for coupling with the gas chromatograph and offers simultaneously recording of ion mobility spectra in both ion polarities during one gas chromatographic separation by using two drift tubes arranged in axial configuration. Feasibility has been demonstrated by building a database of fingerprints of eleven isolated reference samples of anaerobic bacteria with clinical relevance. Preliminary experiments have demonstrated that pattern recognition algorithms can predict the genus of isolated bacteria with a precision of up to 97%.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1582565"},"PeriodicalIF":4.8000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12163022/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1582565","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The rapid identification of bacterial pathogens is critical for the early diagnosis of severe clinical conditions, such as sepsis or implant-associated infections, and for the initiation of timely, targeted therapies. This need is particularly acute within the complex oral microbiome, where diverse opportunistic pathogens contribute to a range of local and systemic diseases. While techniques such as phenotypic systems and MALDI-TOF-MS offer faster results, they remain limited by costs, and operational constraints. To address these challenges and cater to the need for rapid identification of bacteria, we present a system for identification and classification of anaerobic bacteria as a first example. This system combines a pyrolyzer, a gas chromatograph and a highly sensitive ion mobility spectrometer. The ion mobility spectrometer has been optimized for coupling with the gas chromatograph and offers simultaneously recording of ion mobility spectra in both ion polarities during one gas chromatographic separation by using two drift tubes arranged in axial configuration. Feasibility has been demonstrated by building a database of fingerprints of eleven isolated reference samples of anaerobic bacteria with clinical relevance. Preliminary experiments have demonstrated that pattern recognition algorithms can predict the genus of isolated bacteria with a precision of up to 97%.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.